NHS told to expect increase in presentations due to Queen’s death

NHS told to expect increase in presentations due to Queen’s death

There may be an ‘increase’ in patients self-presenting across healthcare services following the Queen’s death, NHS England has said.

Healthcare professionals should also prepare for ‘increased levels’ of did not attends (DNAs) and cancellations during the mourning period with a ‘plan to recover any lost activity’.

In a letter to integrated care boards (ICBs) and NHS ‘provider organisations’ earlier this week, NHS England set out what NHS organisations should ‘consider in their planning’ following the death of the Queen.

Related Article: Warning issued over online weight loss medication

It said: ‘There may be an increase in self-presenters across acute settings/primary care/social care/mental health teams and third sector organisations because of the death.’

Organisations should have ‘a robust mechanism which will assess and refer patients as appropriate’, it added.

The letter also said that ‘primary care and NHS organisations may see increased levels of appointment no-shows and/or cancellations, impacting on electives and clinics during the mourning period or funeral day’.

It added: ‘The organisation should monitor these DNAs and have a plan to recover any lost activity as a result.’

NHS England said that ‘providers, particularly in community and mental health’, should ‘be aware that some patients may be destabilised by the death of Queen Elizabeth II and require additional support’.

Related Article: Cross-sector group to tackle barriers faced by Black pharmacy students

And it added that the Queen’s death ‘is of particular significance to the Armed Forces community and has the potential to trigger mental health issues within that community’.

NHS staff should familiarise themselves with referral pathways to veterans’ mental health and wellbeing service Op COURAGE, it said.

Pharmacists have paid tribute to the Queen following her death on 8 September.

Related Article: SSP for antidepressant medication issued

A version of this story was originally published on our sister publication Pulse. 

Want news like this straight to your inbox?
Sign up for our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.